M-RCBG Senior Fellow Omar Robles will host Sanya Sukduang and Jonathan Davies to discuss U.S. policies promoting the development of novel life-saving drugs while simultaneously increasing accessibility. The panel will address the policy considerations that gave rise to Hatch-Waxman and the BPCIA, how those considerations have played out in practice, and whether the statutory schemes have achieved their goals.
Speakers and Presenters
Omar Robles, M-RCBG Senior Fellow
Sanya Sukduang, Partner at Cooley LLP
Jonathan Davies, Partner at Cooley LLP
This study group is open to all. Registration is not required.